We will be exhibiting at this year's annual DGGF event in Ulm, Germany on the 24th and 25th of September. Come and join us and meet our new Head of Practice for Good Computer Technology and Manufacturing, Carly Davenport and talk to our Consultants about Services...
ADAMAS Consulting started on 1st September 1997 with five full-time auditing staff, based in the UK, but operating globally. ADAMAS’s business goal was “to become the global independent pharmaceutical Quality Assurance service provider of choice” – so how have we...
Mark Poulton recently presented a presentation at an RQA regional forum meeting (Scotland and English Borders, 29-Jan-15) entitled “Audit vs Inspection”. This presentation was intended to awaken minds to the similarities between audits and inspections and to make...
ADAMAS was pleased to have two of its senior staff featured in the July edition of the RQA journal ‘QUASAR’. A professional and personal profile of Dr Christine Henderson, who is a Board Member of RQA and the Quality and Training Director of ADAMAS Consulting, was...
Medication errors are a major public health burden in the European Union (EU). They are the most common preventable cause of adverse events and are estimated to account for 18.7% – 56% of all adverse drug events among hospitalised patients in Europe. Medication errors...
Have you ever wanted to measure your performance across all audits you’ve conducted? Compare your audit results to the overall industry? Or contrast by region? How about having metrics to show senior management your weaknesses, but also your strengths as compared to...
ADAMAS brings Audit Benchmarking Metrics to DIA 2015 unveiling the breakthrough GCP and GVP Audit Benchmarking service. Visit us at booth 2644 and “Move Your Mind” in a new direction when you win your own drone! Did you Know? The term benchmarking was first used by...
ADAMAS Consulting’s APAC Director, Shehnaz Vakharia, will be taking part in a panel discussion on “Quality and Safety Considerations in Clinical Development: Identifying ideal clinical sites and strategizing patient recruitment and clinical sites management in India...
FDA inspectors recently raised concerns over the conduct of multiple trials with the same investigational medicinal product (IMP) under the oversight of the same investigator. A warning letter was issued to one such investigator, as the FDA observed delays in...
Dana Beck, one of our leading Consultants for ADAMAS Consulting in the Americas, was recently honoured by the Society of Quality Assurance and awarded the “Best Poster” accolade at the SQA 2015 Annual Conference held in Tampa, Florida the week of April 12th. Her...
From Reactive Compliance to Strategic Partnership: How Clinical Quality Is Evolving
RQA 8th Global QA Conference 2026 | London, UK
FDA’s Real-Time Clinical Trial Initiative: Endorses Data-Enabled QA Oversight
SCOPE Europe 2026 | Barcelona, Spain
Beyond Audit Cycles: A Risk-Based Approach to Regulatory Excellence in Pharmacovigilance